Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Sales (2018 - 2025)

Historic Return on Sales for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 0.17%.

  • TransMedics' Return on Sales rose 1300.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.08% for FY2024, which is 1900.0% up from last year.
  • Latest data reveals that TransMedics reported Return on Sales of 0.17% as of Q3 2025, which was up 1300.0% from 0.22% recorded in Q2 2025.
  • In the past 5 years, TransMedics' Return on Sales ranged from a high of 0.22% in Q2 2025 and a low of 2.39% during Q3 2021
  • Moreover, its 5-year median value for Return on Sales was 0.06% (2023), whereas its average is 0.39%.
  • In the last 5 years, TransMedics' Return on Sales crashed by -17600bps in 2021 and then surged by 21100bps in 2022.
  • Quarter analysis of 5 years shows TransMedics' Return on Sales stood at 1.5% in 2021, then soared by 85bps to 0.22% in 2022, then skyrocketed by 120bps to 0.05% in 2023, then grew by 25bps to 0.06% in 2024, then soared by 199bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.22% for Q2 2025, and 0.18% during Q1 2025.